imatinib mesylate has been researched along with Polycystic Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imada, K; Miura, M; Onaka, T; Sawada, K; Takahashi, N; Yonezawa, A | 1 |
1 other study(ies) available for imatinib mesylate and Polycystic Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetics of nilotinib in imatinib-resistant/intolerant chronic myeloid leukemia patients on hemodialysis for chronic renal failure.
Topics: Aged; Antineoplastic Agents; Benzamides; Diabetic Nephropathies; Drug Resistance, Neoplasm; Female; Gastrointestinal Hemorrhage; Humans; Imatinib Mesylate; Kidney Failure, Chronic; Leukemia, Myeloid, Chronic-Phase; Lung Diseases, Interstitial; Male; Middle Aged; Nausea; Piperazines; Polycystic Kidney Diseases; Protein Kinase Inhibitors; Pyrimidines; Renal Dialysis | 2012 |